{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T14:34:27Z","timestamp":1792766067507,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100016386","name":"Government of Valencia Ministry of Innovation Universities Science and Society","doi-asserted-by":"publisher","award":["CIPROM\/2024\/12"],"award-info":[{"award-number":["CIPROM\/2024\/12"]}],"id":[{"id":"10.13039\/501100016386","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017642","name":"Spanish National Plan for Scientific and Technical Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017642","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006301","name":"Center for International Business Education and Research, University of Illinois at Urbana-Champaign","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006301","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["CB21\/13\/00011"],"award-info":[{"award-number":["CB21\/13\/00011"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI25\/01250"],"award-info":[{"award-number":["PI25\/01250"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ijid.2026.108925","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T07:41:36Z","timestamp":1782373296000},"page":"108925","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Low prevalence of bacterial coinfection at hospital admission in COVID-19 and the role of procalcitonin as a rule-out biomarker"],"prefix":"10.1016","volume":"170","author":[{"given":"Nuria","family":"Ena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Garc\u00eda-Abell\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Ledesma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Fern\u00e1ndez-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Garc\u00eda-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Padilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9878-2458","authenticated-orcid":false,"given":"Mar","family":"Masi\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9485-6867","authenticated-orcid":false,"given":"F\u00e9lix","family":"Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2026.108925_sbref0001","series-title":"WHO coronavirus (COVID-19) dashboard","year":"2026"},{"issue":"4","key":"10.1016\/j.ijid.2026.108925_bib0002","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1093\/cid\/ciad660","article-title":"Outcomes of SARS-CoV-2 Omicron variant infections compared with seasonal influenza and Respiratory syncytial virus infections in adults attending the emergency department: a multicenter cohort study","volume":"78","author":"Hedberg","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.ijid.2026.108925_bib0003","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1001\/jamainternmed.2024.7452","article-title":"Severity and long-term mortality of COVID-19, influenza, and Respiratory syncytial virus","volume":"185","author":"Bajema","year":"2025","journal-title":"JAMA Intern Med"},{"issue":"4","key":"10.1016\/j.ijid.2026.108925_bib0004","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.cmi.2020.12.018","article-title":"Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis","volume":"27","author":"Langford","year":"2021","journal-title":"Clin Microbiol Infect"},{"issue":"9","key":"10.1016\/j.ijid.2026.108925_bib0005","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/cid\/ciaa530","article-title":"Bacterial and fungal coinfection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing","volume":"71","author":"Rawson","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2026.108925_bib0006","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1206476","article-title":"Bacterial co-infection raises in-hospital mortality of COVID-19 patients: a retrospective study","volume":"14","author":"Zong","year":"2023","journal-title":"Front Microbiol"},{"issue":"1","key":"10.1016\/j.ijid.2026.108925_bib0007","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cmi.2020.07.041","article-title":"Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study","volume":"27","author":"Garcia-Vidal","year":"2021","journal-title":"Clin Microbiol Infect"},{"issue":"12","key":"10.1016\/j.ijid.2026.108925_bib0008","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofae701","article-title":"Prevalence and predictors of concomitant bacterial infections in patients with Respiratory viruses in Ontario: a cohort study","volume":"11","author":"Wang","year":"2024","journal-title":"Open Forum Infect Dis"},{"issue":"4","key":"10.1016\/j.ijid.2026.108925_bib0009","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1093\/eurpub\/ckad060","article-title":"Epidemiology of bacterial co-infections and risk factors in COVID-19-hospitalized patients in Spain: a nationwide study","volume":"33","author":"L\u00f3pez-Herrero","year":"2023","journal-title":"Eur J Public Health"},{"issue":"2","key":"10.1016\/j.ijid.2026.108925_bib0010","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1080\/23744235.2020.1839672","article-title":"Few bacterial co-infections but frequent empiric antibiotic use in the early phase of hospitalized patients with COVID-19: results from a multicentre retrospective cohort study in The Netherlands","volume":"53","author":"Karami","year":"2021","journal-title":"Infect Dis (Lond)"},{"issue":"3","key":"10.1016\/j.ijid.2026.108925_bib0011","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s15010-020-01553-x","article-title":"Bacterial coinfection in critically ill COVID-19 patients with severe pneumonia","volume":"49","author":"Elabbadi","year":"2021","journal-title":"Infection"},{"issue":"4","key":"10.1016\/j.ijid.2026.108925_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2022.06.024","article-title":"Negative predictive value of procalcitonin to rule out bacterial respiratory coinfection in critical COVID19 patients","volume":"85","author":"Carbonell","year":"2022","journal-title":"J Infect"},{"key":"10.1016\/j.ijid.2026.108925_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcrc.2023.154360","article-title":"Inflammatory biomarkers to predict the prognosis of acute bacterial and viral infections","volume":"78","author":"de Nooijer","year":"2023","journal-title":"J Crit Care"},{"issue":"5","key":"10.1016\/j.ijid.2026.108925_bib0014","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1515\/cclm-2022-1072","article-title":"How to best use procalcitonin to diagnose infections and manage antibiotic treatment","volume":"61","author":"Schuetz","year":"2022","journal-title":"Clin Chem Lab Med"},{"issue":"6","key":"10.1016\/j.ijid.2026.108925_bib0015","doi-asserted-by":"crossref","first-page":"594","DOI":"10.3390\/medicina57060594","article-title":"Elevated procalcitonin is positively associated with the severity of COVID-19: a meta-analysis based on 10 cohort studies","volume":"57","author":"Shen","year":"2021","journal-title":"Medicina (Kaunas)"},{"issue":"2","key":"10.1016\/j.ijid.2026.108925_bib0016","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s44197-022-00038-4","article-title":"Bacterial and fungal coinfection in critically ill COVID-19 cases and predictive role of procalcitonin during the first wave at an academic health center","volume":"12","author":"Alnimr","year":"2022","journal-title":"J Epidemiol Glob Health"},{"key":"10.1016\/j.ijid.2026.108925_bib0017","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/978-3-030-59261-5_25","article-title":"The level of procalcitonin in severe COVID-19 patients: a systematic review and meta-analysis","volume":"1321","author":"Heidari-Beni","year":"2021","journal-title":"Adv Exp Med Biol"},{"issue":"9","key":"10.1016\/j.ijid.2026.108925_bib0018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0272840","article-title":"Procalcitonin as a predictive marker in COVID-19: a systematic review and meta-analysis","volume":"17","author":"Kumar","year":"2022","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ijid.2026.108925_bib0019","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12985-023-02042-x","article-title":"Predictive values of procalcitonin for coinfections in patients with COVID-19: a systematic review and meta-analysis","volume":"20","author":"Wei","year":"2023","journal-title":"Virol J"},{"issue":"19","key":"10.1016\/j.ijid.2026.108925_bib0020","doi-asserted-by":"crossref","first-page":"6171","DOI":"10.3390\/jcm12196171","article-title":"Reduced reliability of procalcitonin (PCT) as a biomarker of bacterial superinfection: concerns about PCT-driven antibiotic stewardship in critically ill COVID-19 patients-results from a retrospective observational study in intensive care units","volume":"12","author":"Ceccarelli","year":"2023","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.ijid.2026.108925_bib0021","article-title":"Nonutility of procalcitonin for diagnosing bacterial pneumonia in patients with severe COVID-19","volume":"10","author":"Cohen","year":"2023","journal-title":"Eur Clin Respir J"},{"issue":"1","key":"10.1016\/j.ijid.2026.108925_bib0022","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-74001-3","article-title":"Preemptive interleukin-6 blockade in patients with COVID-19","volume":"10","author":"Guill\u00e9n","year":"2020","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.ijid.2026.108925_bib0023","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1093\/jac\/dkac144","article-title":"Survival benefit of remdesivir in hospitalized COVID-19 patients with high SARS-CoV-2 viral loads and low-grade systemic inflammation","volume":"77","author":"Padilla","year":"2022","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2026.108925_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104153","article-title":"Robust long-term immunity to SARS-CoV-2 in patients recovered from severe COVID-19 after interleukin-6 blockade","volume":"82","author":"Masi\u00e1","year":"2022","journal-title":"EBioMedicine"},{"issue":"8","key":"10.1016\/j.ijid.2026.108925_bib0025","doi-asserted-by":"crossref","first-page":"e192","DOI":"10.1016\/S1473-3099(20)30483-7","article-title":"A minimal common outcome measure set for COVID-19 clinical research","volume":"20","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10.1016\/j.ijid.2026.108925_bib0026","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/irv.12398","article-title":"The frequency of influenza and bacterial coinfection: a systematic review and meta-analysis","volume":"10","author":"Klein","year":"2016","journal-title":"Influenza Other Respir Viruses"},{"issue":"6","key":"10.1016\/j.ijid.2026.108925_bib0027","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1007\/s15010-025-02590-0","article-title":"The effect of antibiotic therapy on clinical outcome in patients hospitalized with moderate COVID-19 disease: a prospective multi-center cohort study","volume":"53","author":"Friedrichs","year":"2025","journal-title":"Infection"},{"key":"10.1016\/j.ijid.2026.108925_bib0028","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.2147\/IDR.S470957","article-title":"The impact of early antibiotic use on clinical outcomes of patients hospitalized with COVID-19: a propensity score-matched analysis","volume":"17","author":"Duan","year":"2024","journal-title":"Infect Drug Resist"},{"issue":"11","key":"10.1016\/j.ijid.2026.108925_bib0029","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1093\/jac\/dkae246","article-title":"A retrospective propensity-score-matched cohort study of the impact of procalcitonin testing on antibiotic use in hospitalized patients during the first wave of COVID-19","volume":"79","author":"Sandoe","year":"2024","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"10.1016\/j.ijid.2026.108925_bib0030","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-093210","article-title":"Procalcitonin to guide antibiotic use during the first wave of COVID-19 in English and Welsh hospitals: integration and triangulation of findings from quantitative and qualitative sources","volume":"15","author":"Henley","year":"2025","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.ijid.2026.108925_bib0031","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1093\/jac\/dkac017","article-title":"Impact of introducing procalcitonin testing on antibiotic usage in acute NHS hospitals during the first wave of COVID-19 in the UK: a controlled interrupted time series analysis of organization-level data","volume":"77","author":"Llewelyn","year":"2022","journal-title":"J Antimicrob Chemother"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226005606?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226005606?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:54:45Z","timestamp":1791212085000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971226005606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":31,"alternative-id":["S1201971226005606"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108925","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low prevalence of bacterial coinfection at hospital admission in COVID-19 and the role of procalcitonin as a rule-out biomarker","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108925","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"108925"}}